PIM
MDT icon

Penobscot Investment Management’s Medtronic MDT Stock Holding History

Penobscot Investment Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,168
Closed -$208K – 319
2025
Q4 		$208K Sell
2,168
-2
-0.1% -$194 0.02% 309
2025
Q3 		$207K Sell
2,170
-1,350
-38% -$124K 0.02% 312
2025
Q2 		$307K Sell
3,520
-106
-3% -$8.99K 0.03% 263
2025
Q1 		$326K Buy
3,626
+138
+4% +$12.3K 0.03% 250
2024
Q4 		$279K Sell
3,488
-207
-6% -$17.9K 0.03% 264
2024
Q3 		$333K Sell
3,695
-575
-13% -$48.4K 0.03% 254
2024
Q2 		$336K Sell
4,270
-1,271
-23% -$104K 0.03% 244
2024
Q1 		$483K Sell
5,541
-2,525
-31% -$215K 0.05% 206
2023
Q4 		$664K Sell
8,066
-2,594
-24% -$198K 0.08% 179
2023
Q3 		$838K Buy
10,660
+3,745
+54% +$314K 0.11% 152
2023
Q2 		$609K Sell
6,915
-1,925
-22% -$166K 0.1% 140
2023
Q1 		$713K Sell
8,840
-4,234
-32% -$345K 0.12% 132
2022
Q4 		$1.02M Sell
13,074
-302
-2% -$24.5K 0.18% 110
2022
Q3 		$1.08M Sell
13,376
-1,051
-7% -$94.5K 0.2% 103
2022
Q2 		$1.29M Buy
14,427
+19
+0.1% +$1.93K 0.22% 102
2022
Q1 		$1.6M Buy
14,408
+1,634
+13% +$173K 0.23% 99
2021
Q4 		$1.32M Buy
12,774
+258
+2% +$29.9K 0.18% 115
2021
Q3 		$1.57M Buy
12,516
+60
+0.5% +$7.77K 0.23% 103
2021
Q2 		$1.55M Sell
12,456
-2,000
-14% -$251K 0.23% 104
2021
Q1 		$1.71M Hold
14,456
– – 0.27% 93
2020
Q4 		$1.69M Buy
14,456
+200
+1% +$22K 0.28% 85
2020
Q3 		$1.48M Hold
14,256
– – 0.28% 83
2020
Q2 		$1.31M Hold
14,256
– – 0.27% 84
2020
Q1 		$1.28M Hold
14,256
– – 0.3% 80
2019
Q4 		$1.62M Hold
14,256
– – 0.3% 85
2019
Q3 		$1.55M Sell
14,256
-150
-1% -$15.7K 0.31% 85
2019
Q2 		$1.4M Sell
14,406
-375
-3% -$34.2K 0.29% 88
2019
Q1 		$1.35M Hold
14,781
– – 0.29% 88
2018
Q4 		$1.34M Sell
14,781
-250
-2% -$23.4K 0.32% 80
2018
Q3 		$1.48M Sell
15,031
-65
-0.4% -$6.01K 0.32% 80
2018
Q2 		$1.29M Sell
15,096
-829
-5% -$69.2K 0.3% 87
2018
Q1 		$1.28M Buy
15,925
+10,120
+174% +$835K 0.31% 84
2017
Q4 		$469K Sell
5,805
-500
-8% -$40K 0.13% 128
2017
Q3 		$490K Hold
6,305
– – 0.15% 126
2017
Q2 		$560K Buy
6,305
+79
+1% +$6.66K 0.18% 116
2017
Q1 		$502K Buy
6,226
+1,775
+40% +$139K 0.17% 115
2016
Q4 		$317K Sell
4,451
-50
-1% -$3.93K 0.11% 141
2016
Q3 		$389K Hold
4,501
– – 0.14% 133
2016
Q2 		$391K Sell
4,501
-350
-7% -$28.3K 0.14% 132
2016
Q1 		$364K Sell
4,851
-95
-2% -$7.16K 0.14% 133
2015
Q4 		$381K Hold
4,946
– – 0.12% 142
2015
Q3 		$331K Hold
4,946
– – 0.11% 148
2015
Q2 		$367K Hold
4,946
– – 0.11% 154
2015
Q1 		$386K Buy
4,946
+946
+24% +$71.7K 0.12% 142
2014
Q4 		$289K Hold
4,000
– – 0.09% 155
2014
Q3 		$248K Hold
4,000
– – 0.08% 163
2014
Q2 		$255K Buy
+4,000
New +$243K 0.09% 154

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Penobscot Investment Management's MDT Position: Q1 2026 in Review

Penobscot Investment Management sold out of Medtronic (MDT) in Q1 2026, closing a stake of 2,168 shares — an estimated $208K sold.

Penobscot Investment Management first reported a position in MDT in Q2 2014 and held it in 47 quarters. The position peaked at $1.71M in Q1 2021. 2,244 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Penobscot Investment Management reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
  • Penobscot Investment Management sold 2,168 Medtronic shares in Q1 2026, an estimated $208K.
  • Penobscot Investment Management first reported a position in Medtronic in Q2 2014 and held it in 47 quarters.
  • Penobscot Investment Management's Medtronic position peaked at $1.71M in Q1 2021.
  • 2,244 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Penobscot Investment Management's 13F filing for Q1 2026, filed 29 Apr 2026.